| Literature DB >> 32499670 |
Abstract
Catheter ablation (CA) of the pulmonary veins for atrial fibrillation (AF) is growing exponentially and is the most commonly performed electrophysiologic procedure. Initial descriptions focused on CA for paroxysmal AF, and now more recently expanded in application to persistent AF and those with comorbid heart failure. Efforts to improve success have and continue to address issues such as pulmonary vein "reconnection" following ablation through different ablative energy modalities, and the use of a "hybrid" surgical/endocardial combined approach in persistent forms of AF. Technologic advances as well are concurrently seeking to improve safety, particularly regarding the incidence of atrio-esophageal fistula in this seemingly ever-growing ablation population. © Thieme Medical Publishers.Entities:
Keywords: atrial fibrillation; catheter ablation; clinical trials; ejection fraction; electrophysiology; paroxysmal atrial fibrillation; pulmonary vein isolation
Year: 2020 PMID: 32499670 PMCID: PMC7253347 DOI: 10.1055/s-0040-1708476
Source DB: PubMed Journal: Int J Angiol ISSN: 1061-1711